News Focus
News Focus
Followers 59
Posts 7595
Boards Moderated 0
Alias Born 10/20/2014

Re: Number sleven post# 406151

Thursday, 03/23/2023 7:17:00 AM

Thursday, March 23, 2023 7:17:00 AM

Post# of 447970
Number sleven, Yes, Interesting indeed! (On many levels.)
The sponsor of the study is the largest private pharmaceutical company in the world.
(Based in Germany.) Could they be a prospect to acquire AMRN? Could they help
to get reimbursement for Vazkepa in Germany? (Well, maybe if the owned it.)
Will AMRN management use this article to strengthen their argument with German
Health authorities? (I hope so, that is if the are even aware of this article.)
Have you sent it over to AMRN, and if so, any response?)

This article certainly captures the medical justification for Vazkepa.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News